ImaginAb Roundtable

Imaging may improve decision making in early IO clinical trials

An engaging discussion with our expert panel:

Please note

The content within the recording and the transcript of the Roundtable on how “imaging may improve decision making in IO clinical trials” that took place on December 5th 2021, has been made available for informational and educational purposes only. This information is only available to pharmaceutical and biotech personnel working on projects related to IO clinical trials.

The efficacy and safety of ImaginAb’s investigational CD8 ImmunoPET technology (zirconium Zr 89 crefmirlimab berdoxam) discussed during the Roundtable event have not been established. There is no guarantee that these compounds will become commercially available for the use(s) under investigation

Please return to the knowledge hub to review all of the content from the roundtable.